Growing community of inventors

Boston, MA, United States of America

Vikram R Juneja

Average Co-Inventor Count = 8.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 1

Vikram R JunejaGordon James Freeman (3 patents)Vikram R JunejaArlene Helen Sharpe (3 patents)Vikram R JunejaVassiliki A Boussiotis (2 patents)Vikram R JunejaXia Bu (2 patents)Vikram R JunejaNikolaos Patsoukis (2 patents)Vikram R JunejaJessica Weaver (2 patents)Vikram R JunejaLaura Strauss (2 patents)Vikram R JunejaLoise M Francisco (1 patent)Vikram R JunejaPeter T Sage (1 patent)Vikram R JunejaScott B Lovitch (1 patent)Vikram R JunejaCatherine L Tan (1 patent)Vikram R JunejaSun J Lee (1 patent)Vikram R JunejaArlene H Sharpe (0 patent)Vikram R JunejaVikram R Juneja (3 patents)Gordon James FreemanGordon James Freeman (90 patents)Arlene Helen SharpeArlene Helen Sharpe (35 patents)Vassiliki A BoussiotisVassiliki A Boussiotis (9 patents)Xia BuXia Bu (2 patents)Nikolaos PatsoukisNikolaos Patsoukis (2 patents)Jessica WeaverJessica Weaver (2 patents)Laura StraussLaura Strauss (2 patents)Loise M FranciscoLoise M Francisco (6 patents)Peter T SagePeter T Sage (4 patents)Scott B LovitchScott B Lovitch (1 patent)Catherine L TanCatherine L Tan (1 patent)Sun J LeeSun J Lee (1 patent)Arlene H SharpeArlene H Sharpe (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Harvard College (3 from 2,963 patents)

2. Dana-farber-cancer Institute Inc. (3 from 1,209 patents)

3. Beth Israel Deaconess Medical Center, Inc. (2 from 517 patents)

4. The Brigham and Women's Hospital, Inc. (1 from 1,373 patents)

5. Sharpe, Arlene, H. (0 patent)

6. Francisco, Loise M. (0 patent)

7. Lovitch, Scott B. (0 patent)

8. Freeman, Gordon J. (0 patent)

9. Tan, Catherine L. (0 patent)

10. Sage, Peter T. (0 patent)

11. Juneja, Vikram R. (0 patent)

12. Lee, Sun J. (0 patent)


3 patents:

1. 12258409 - Method of assessing the efficacy of a test agent for modulating programmed death 1 (PD-1) signaling by using anti-phosphotyrosinylated PD-1 monoclonal antibodies

2. 11492403 - Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, methods of making and methods of using thereof

3. 11207393 - Regulatory T cell PD-1 modulation for regulating T cell effector immune responses

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/28/2025
Loading…